GSK rolls out 2D data-matrix system

Drug giant GlaxoSmithKline is outfitting 65 packaging lines at 17 manufacturing sites across 12 countries with new coding equipment, in preparation for the January 1, 2011, start of France's CIP13 coding requirements. The mandate requires that drug products carry a 2D data-matrix mark incorporating the 13-digit CIP13 code, batch number and expiration date.

Packaging lines in France and Italy are currently printing the codes. GSK expects the rollout to be complete by October. The effort encompasses nearly a quarter of the big pharma's packaging lines worldwide.

The CIP13 code is batch-specific and not a randomized serialization scheme, reports SecuringPharma. So GSK designed a system to encompass pack-level traceability, which is likely to be mandated in the future. The current system has four variants, include one for tamper-evident label and another for an offline coding system intended for small quantity production runs.

The coding equipment uses a thermal inkjet printing system that can accommodate line speeds to 400 packs per minute. Thermal inkjet technology beat out laser coding based on speed and image quality.

- see the article
- here's a track and trace overview


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.